All In MedTech

FDA Clearance Tracker · P990056-S007

ELECSYS TOTAL PSA IMMUNOASSAY AND ELECYS TOTAL PSA CALSET

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 18, 2008 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 18, 2008

Approved

Time to decision

454 days

Received Aug 22, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990056-S007
Device name
ELECSYS TOTAL PSA IMMUNOASSAY AND ELECYS TOTAL PSA CALSET
Applicant location
Indianapolis, IN
Received
Aug 22, 2007
Decided
Nov 18, 2008
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P990056

Device type

Device class
Class III

Every decision under product code MTF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR EXTENSION OF THE ELECSYS TOTAL PSA AND CALSET II ONTO THE UPDATED MODEL OF THE ELECSYS 2010 ANALYZER, COBAS E 411 ANALYZER.

Source documents

Other decisions for Roche Diagnostics Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.